Your shopping cart is empty




You are about to log out of VaccineShoppe.com.

Would you like to place your order before you log out?

Log Out Continue Shopping

Prescribing Information

Before administering Fluzone Quadrivalent vaccine, please see full Prescribing Information.
 

Reimbursement Information

Fluzone® Quadrivalent

(Influenza Vaccine)

For persons 36 months of age and older

Log in to order

About Fluzone Quadrivalent Vaccine

 

IMPORTANT SAFETY INFORMATION FOR FLUZONE QUADRIVALENT VACCINE

Fluzone Quadrivalent vaccine should not be administered to anyone who has had a severe allergic reaction (eg, anaphylaxis) to any vaccine component, including egg protein or thimerosal (the multidose vial is the only presentation containing thimerosal), or to a previous dose of any influenza vaccine.

If Guillain-Barré syndrome has occurred within 6 weeks following previous influenza vaccination, the decision to give Fluzone Quadrivalent vaccine should be based on careful consideration of the potential benefits and risks.

The most common local adverse reactions to Fluzone Quadrivalent vaccine include pain at the injection site (all ages) and erythema and swelling at the injection site (in children). The most common systemic reactions include myalgia, malaise, and headache (irritability, abnormal crying, drowsiness, appetite loss, vomiting, and fever in young children). Other adverse reactions may occur. Vaccination with Fluzone Quadrivalent vaccine may not protect all individuals.

 

INDICATION FOR FLUZONE QUADRIVALENT VACCINE

Fluzone Quadrivalent vaccine is indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Fluzone Quadrivalent vaccine is approved for use in persons 6 months of age and older.

 

 

 

MKT33121

This website requires the use of cookies, but your web browser is not accepting them. Please enable cookies in order to use this site.
OK